Aphria Inc reported CAD153.64M in Sales Revenues for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Ani Pharmaceuticals ANIP:US $ 52.06M 3.44M
Aurora Cannabis Inc ACB:CN 60.11M 5.5M
Canopy Growth Corp WEED:CN C$ 131.37M 4.84M
Corcept Therapeutics CORT:US $ 96.13M 4.54M
Cronos Group Inc CRON:CN 15.62M 3.01M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Lannett LCI:US $ 101.52M 4.48M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Pacira Pharmaceuticals PCRX:US $ 127.72M 7.87M
Supernus Pharmaceuticals SUPN:US $ 148.46M 7.14M